These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25360214)

  • 21. Protective roles of B and T lymphocyte attenuator in NKT cell-mediated experimental hepatitis.
    Iwata A; Watanabe N; Oya Y; Owada T; Ikeda K; Suto A; Kagami S; Hirose K; Kanari H; Kawashima S; Nakayama T; Taniguchi M; Iwamoto I; Nakajima H
    J Immunol; 2010 Jan; 184(1):127-33. PubMed ID: 19949073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].
    Han LF; Qiu WM; Hu C; Wang L; Yao HX; Xiong SY; Meng M; Fang Y; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):603-8. PubMed ID: 21029617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of BTLA and B7-H4 on the surface of myeloid dendritic cells has a negative regulatory effect on their anti-tuberculosis immunity activity in pleural tuberculosis patients.
    Cai X; Ge N; Rong R; Lu Y; Zhang J; Xu J
    Tuberculosis (Edinb); 2019 Dec; 119():101877. PubMed ID: 31677529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients.
    Karabon L; Partyka A; Ciszak L; Pawlak-Adamska E; Tomkiewicz A; Bojarska-Junak A; Roliński J; Wołowiec D; Wrobel T; Frydecka I; Kosmaczewska A
    J Immunol Res; 2020; 2020():6545921. PubMed ID: 32775467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B- and T-lymphocyte attenuator targeting protects against the acute phase of graft versus host reaction by inhibiting donor anti-host cytotoxicity.
    del Rio ML; Kurtz J; Perez-Martinez C; Ghosh A; Perez-Simon JA; Rodriguez-Barbosa JI
    Transplantation; 2011 Nov; 92(10):1085-93. PubMed ID: 21978997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
    Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H
    J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of the numbers and subsets of MTB-HAg specific TNF-α
    Tang J; Chen C; Zha C; Wang Z; Zhang C; Zeng L; Li B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Nov; 32(11):1527-1531. PubMed ID: 27774949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperglycaemia is inversely correlated with live M. bovis BCG-specific CD4
    Boillat-Blanco N; Tumbo AN; Perreau M; Amelio P; Ramaiya KL; Mganga M; Schindler C; Gagneux S; Reither K; Probst-Hensch N; Pantaleo G; Daubenberger C; Portevin D
    Immun Inflamm Dis; 2018 Jun; 6(2):345-353. PubMed ID: 29642283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B- and T-lymphocyte attenuator stimulation protects against atherosclerosis by regulating follicular B cells.
    Douna H; Amersfoort J; Schaftenaar FH; Kröner MJ; Kiss MG; Slütter B; Depuydt MAC; Bernabé Kleijn MNA; Wezel A; Smeets HJ; Yagita H; Binder CJ; Bot I; van Puijvelde GHM; Kuiper J; Foks AC
    Cardiovasc Res; 2020 Feb; 116(2):295-305. PubMed ID: 31150053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B and T lymphocyte attenuator restricts the protective immune response against experimental malaria.
    Adler G; Steeg C; Pfeffer K; Murphy TL; Murphy KM; Langhorne J; Jacobs T
    J Immunol; 2011 Nov; 187(10):5310-9. PubMed ID: 21998455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity.
    Rai PK; Chodisetti SB; Zeng W; Nadeem S; Maurya SK; Pahari S; Janmeja AK; Jackson DC; Agrewala JN
    J Transl Med; 2017 Oct; 15(1):201. PubMed ID: 28985739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease.
    Rozot V; Vigano S; Mazza-Stalder J; Idrizi E; Day CL; Perreau M; Lazor-Blanchet C; Petruccioli E; Hanekom W; Goletti D; Bart PA; Nicod L; Pantaleo G; Harari A
    Eur J Immunol; 2013 Jun; 43(6):1568-77. PubMed ID: 23456989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection.
    Zhao HM; Du R; Li CL; Ji P; Li HC; Wu K; Hu Z; Lu SH; Lowrie DB; Fan XY
    J Infect; 2019 Apr; 78(4):275-280. PubMed ID: 30528871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigens of
    Choreño-Parra JA; Jiménez-Álvarez LA; Muñoz-Torrico M; Ramírez-Martínez G; Jiménez-Zamudio LA; Salinas-Lara C; García-Latorre EA; Zúñiga J
    Front Immunol; 2020; 11():582414. PubMed ID: 33117393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells.
    Tao R; Wang L; Murphy KM; Fraser CC; Hancock WW
    J Immunol; 2008 May; 180(10):6649-55. PubMed ID: 18453584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PD-1 Expression on
    Day CL; Abrahams DA; Bunjun R; Stone L; de Kock M; Walzl G; Wilkinson RJ; Burgers WA; Hanekom WA
    Front Immunol; 2018; 9():1995. PubMed ID: 30233588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B and T lymphocyte attenuator inhibits LPS-induced endotoxic shock by suppressing Toll-like receptor 4 signaling in innate immune cells.
    Kobayashi Y; Iwata A; Suzuki K; Suto A; Kawashima S; Saito Y; Owada T; Kobayashi M; Watanabe N; Nakajima H
    Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5121-6. PubMed ID: 23479601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.
    Adekambi T; Ibegbu CC; Kalokhe AS; Yu T; Ray SM; Rengarajan J
    PLoS One; 2012; 7(4):e36046. PubMed ID: 22545156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutting edge: B and T lymphocyte attenuator signaling on NKT cells inhibits cytokine release and tissue injury in early immune responses.
    Miller ML; Sun Y; Fu YX
    J Immunol; 2009 Jul; 183(1):32-6. PubMed ID: 19535622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area.
    Silva LC; Silveira GG; Arnone M; Romiti R; Geluk A; Franken KC; Duarte AJ; Takahashi MD; Benard G
    Arch Dermatol Res; 2010 May; 302(4):255-62. PubMed ID: 19609541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.